Silo Pharma, Inc. (SILO)
SILO Stock Price Chart
Explore Silo Pharma, Inc. interactive price chart. Choose custom timeframes to analyze SILO price movements and trends.
SILO Company Profile
Discover essential business fundamentals and corporate details for Silo Pharma, Inc. (SILO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Jan 2021
Employees
3.00
Website
https://silopharma.comCEO
Eric Weisblum
Description
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.
SILO Financial Timeline
Browse a chronological timeline of Silo Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.32, while revenue estimate is $18.00k.
Stock split effective on 3 Jun 2026
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2026
EPS came in at -$1.80 falling short of the estimated -$0.32 by -462.50%, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 27 Mar 2026
EPS came in at -$0.99 , while revenue for the quarter reached $18.03k .
Earnings released on 13 Nov 2025
EPS came in at -$0.12 surpassing the estimated -$0.20 by +40.00%, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 13 Aug 2025
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 9 May 2025
EPS came in at -$0.23 falling short of the estimated -$0.21 by -9.52%, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 28 Mar 2025
EPS came in at -$0.41 falling short of the estimated -$0.20 by -105.00%, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 12 Nov 2024
EPS came in at -$0.22 falling short of the estimated -$0.21 by -4.76%, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 13 Aug 2024
EPS came in at -$0.31 surpassing the estimated -$0.32 by +3.13%, while revenue for the quarter reached $18.00k , meeting expectations.
Earnings released on 13 May 2024
EPS came in at -$0.28 falling short of the estimated -$0.21 by -33.33%, while revenue for the quarter reached $18.00k , meeting expectations.
Earnings released on 25 Mar 2024
EPS came in at -$0.36 falling short of the estimated -$0.20 by -80.00%, while revenue for the quarter reached $18.00k , meeting expectations.
Earnings released on 13 Nov 2023
EPS came in at -$0.21 falling short of the estimated -$0.20 by -5.00%, while revenue for the quarter reached $18.03k , missing expectations by -9.88%.
Earnings released on 11 Aug 2023
EPS came in at -$0.32 matching the estimated -$0.32, while revenue for the quarter reached $18.03k , beating expectations by +0.14%.
Earnings released on 12 May 2023
EPS came in at -$0.29 , while revenue for the quarter reached $18.03k .
Earnings released on 24 Mar 2023
EPS came in at -$0.78 , while revenue for the quarter reached $18.03k .
Earnings released on 10 Nov 2022
EPS came in at -$0.51 , while revenue for the quarter reached $18.03k .
Stock split effective on 15 Sept 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Aug 2022
EPS came in at -$0.41 , while revenue for the quarter reached $18.03k .
Earnings released on 13 May 2022
EPS came in at -$0.31 , while revenue for the quarter reached $18.03k .
Earnings released on 28 Mar 2022
EPS came in at -$0.57 , while revenue for the quarter reached $18.03k .
Earnings released on 11 Nov 2021
EPS came in at $3.16 , while revenue for the quarter reached $18.03k .
Earnings released on 13 Aug 2021
EPS came in at -$0.24 , while revenue for the quarter reached $18.03k .
SILO Stock Performance
Access detailed SILO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
